Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Miyakoshi J et al. | 2000 | intact cell/cell culture, MO54 cells (derived from a human malignant glioma) | magnetic field, 50/60 Hz, co-exposure | 5–400 mT |
Ansari RM et al. | 2000 | intact cell/cell culture, human-hamster hybrid cells | magnetic field, 50/60 Hz, co-exposure | 100 µT |
Loberg LI et al. | 2000 | intact cell/cell culture, MCF-7, ZR-75-1, T-47D, and MDA-MB-231 (breast cancer cell line) and normal human breast epithalial cells | magnetic field, 50/60 Hz | 1 mT |
Ramstad S et al. | 2000 | bacterium, <i>Propionibacterium acnes</i> | electric field, magnetic field, 50/60 Hz | 200 µT |
Gamble SC et al. | 1999 | intact cell/cell culture, SHD (syrian hamster dermal) cells | magnetic field, 50/60 Hz, power transmission line, co-exposure | 10–1,000 µT |
Pieroni L et al. | 1998 | intact cell/cell culture, virus/bacteriophages, murine B lymphocytes and T lymphocytes infected with a murine retrovirus (Mo-MLV) | magnetic field, 50/60 Hz | 1 mT |
Reipert BM et al. | 1997 | intact cell/cell culture, FDCP-mix(A4) cell line (mouse bone marrow cells) | magnetic field, static magnetic field, 50/60 Hz, shielding/field deprivation | 0.2 µT–2 mT |
Miyakoshi J et al. | 1997 | intact cell/cell culture, MeWo cells (malignant melanoma cells) | magnetic field, 50/60 Hz, also other exposures without EMF | 400–500 mT |
Schimmelpfeng J | 1997 | intact cell/cell culture, HL-60 (human promyelocytic leukemia cells) | magnetic field, 50/60 Hz, co-exposure | 2 mT |
Eremenko T et al. | 1997 | intact cell/cell culture, Friend erythroleukemia cell line (clone 745 A) | magnetic field, geomagnetic field, 50/60 Hz, shielding/field deprivation | 0.0025 nT–70 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.